To estimate the impact of porcine parvovirus (PPV) vaccines on the emergence of new phenotypes, the population dynamic history of the virus was calculated using the Bayesian Markov chain Monte Carlo method with a Bayesian skyline coalescent model. Additionally, an in vitro model was performed with consecutive passages of the ‘Challenge’ strain (a virulent field strain) and NADL2 strain (a vaccine strain) in a PK-15 cell line supplemented with polyclonal antibodies raised against the vaccine strain. A decrease in genetic diversity was observed in the presence of antibodies in vitro or after vaccination (as estimated by the in silico model). We hypothesized that the antibodies induced a selective pressure that may reduce the incidence of neutral selection, which should play a major role in the emergence of new mutations. In this scenario, vaccine failures and non-vaccinated populations (e.g. wild boars) may have an important impact in the emergence of new phenotypes.
BergeronJ., HébertB., TijssenP.1996; Genome organization of the Kresse strain of porcine parvovirus: identification of the allotropic determinant and comparison with those of NADL-2 and field isolates. J Virol 70:2508–2515[PubMed]
FernandesS., BoisvertM., TijssenP.2011; Genetic elements in the VP region of porcine parvovirus are critical to replication efficiency in cell culture. J Virol 85:3025–3029 [View Article][PubMed]
JóźwikA., ManteufelJ., SelbitzH. J., TruyenU.2009; Vaccination against porcine parvovirus protects against disease, but does not prevent infection and virus shedding after challenge infection with a heterologous virus strain. J Gen Virol 90:2437–2441 [View Article][PubMed]
Martins SoaresR., CortezA., HeinemannM. B., SakamotoS. M., MartinsV. G., BacciM.Jr, De Campos FernandesF. M., RichtzenhainL. J.2003; Genetic variability of porcine parvovirus isolates revealed by analysis of partial sequences of the structural coding gene VP2. J Gen Virol 84:1505–1515 [View Article][PubMed]
MengelingW. L.1975; Porcine parvovirus: frequency of naturally occurring transplacental infection and viral contamination of fetal porcine kidney cell cultures. Am J Vet Res 36:41–44[PubMed]
SimpsonA. A., HébertB., SullivanG. M., ParrishC. R., ZádoriZ., TijssenP., RossmannM. G.2002; The structure of porcine parvovirus: comparison with related viruses. J Mol Biol 315:1189–1198 [View Article][PubMed]
StreckA. F., BonattoS. L., HomeierT., SouzaC. K., GonçalvesK. R., GavaD., CanalC. W., TruyenU.2011; High rate of viral evolution in the capsid protein of porcine parvovirus. J Gen Virol 92:2628–2636 [View Article][PubMed]
TruyenU., StreckA. F.2012; Porcine parvovirus. In Diseases of Swine, 10th edn. pp. 447–455 Edited by ZimmermanJ., KarrikerL., RamirezA., SchwartzK., StevensonG. Oxford: John Wiley & Sons;
van BallegooijenW. M., van HoudtR., BruistenS. M., BootH. J., CoutinhoR. A., WallingaJ.2009; Molecular sequence data of hepatitis B virus and genetic diversity after vaccination. Am J Epidemiol 170:1455–1463 [View Article][PubMed]
ZeeuwE. J. L., LeineckerN., HerwigV., SelbitzH. J., TruyenU.2007; Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts. J Gen Virol 88:420–427 [View Article][PubMed]